BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2897430)

  • 1. Selective destruction of cultured dopaminergic neurons from fetal rat mesencephalon by 1-methyl-4-phenylpyridinium: cytochemical and morphological evidence.
    Sanchez-Ramos JR; Michel P; Weiner WJ; Hefti F
    J Neurochem; 1988 Jun; 50(6):1934-44. PubMed ID: 2897430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-Methyl-4-phenylpyridinium (MPP+) but not 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) selectively destroys dopaminergic neurons in cultures of dissociated rat mesencephalic neurons.
    Sanchez-Ramos J; Barrett JN; Goldstein M; Weiner WJ; Hefti F
    Neurosci Lett; 1986 Dec; 72(2):215-20. PubMed ID: 2880321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The toxicity of MPTP to dopamine neurons in culture is reduced at high concentrations.
    Friedman L; Mytilineou C
    Neurosci Lett; 1987 Aug; 79(1-2):65-72. PubMed ID: 2890125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic cultures.
    Michel PP; Agid Y
    Brain Res; 1992 Dec; 597(2):233-40. PubMed ID: 1361874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional changes in cocultures of mesencephalon and striatal neurons from embryonic C57/BL6 mice due to low concentrations of 1-methyl-4-phenylpyridinium (MPP+).
    Koutsilieri E; Chan WW; Reinitzer D; Rausch WD
    J Neural Transm Gen Sect; 1993; 94(3):189-97. PubMed ID: 7907217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity of 1-methyl-4-phenylpyridinium for rat dopaminergic neurons in culture: selectivity and irreversibility.
    Michel PP; Dandapani BK; Knusel B; Sanchez-Ramos J; Hefti F
    J Neurochem; 1990 Apr; 54(4):1102-9. PubMed ID: 1968953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF.
    Park TH; Mytilineou C
    Brain Res; 1992 Dec; 599(1):83-97. PubMed ID: 1362921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF-2-mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: specificity and impact of culture conditions, non-dopaminergic neurons, and astroglial cells.
    Otto D; Unsicker K
    J Neurosci Res; 1993 Mar; 34(4):382-93. PubMed ID: 8097265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesencephalic dopamine neurons become less sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity during development in vitro.
    Danias P; Nicklas WJ; Ofori S; Shen J; Mytilineou C
    J Neurochem; 1989 Oct; 53(4):1149-55. PubMed ID: 2788714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism and 1-methyl-4-phenylpyridinium uptake in dissociated cell cultures from the embryonic mesencephalon.
    Schinelli S; Zuddas A; Kopin IJ; Barker JL; di Porzio U
    J Neurochem; 1988 Jun; 50(6):1900-7. PubMed ID: 3259619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
    Vaglini F; Pardini C; Cavalletti M; Maggio R; Corsini GU
    Brain Res; 1996 Nov; 741(1-2):68-74. PubMed ID: 9001706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 1-methyl-4-phenylpyridinium ion (MPP+) on catecholamine levels and activity of related enzymes in clonal rat pheochromocytoma PC12h cells.
    Naoi M; Takahashi T; Nagatsu T
    Life Sci; 1988; 43(18):1485-91. PubMed ID: 2903426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic effects of potential environmental neurotoxins related to 1-methyl-4-phenylpyridinium on cultured rat dopaminergic neurons.
    Michel PP; Dandapani BK; Sanchez-Ramos J; Efange S; Pressman BC; Hefti F
    J Pharmacol Exp Ther; 1989 Feb; 248(2):842-50. PubMed ID: 2783974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential environmental neurotoxins related to 1-methyl-4-phenylpyridinium: selective toxicity of 1-methyl-4-(4'-acetamidophenyl)-pyridinium and 1-methyl-4-cyclohexylpyridinium for dopaminergic neurons in culture.
    Michel PP; Dandapani BK; Efange SM; Hefti F
    Exp Neurol; 1990 May; 108(2):141-50. PubMed ID: 2335192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (Mpp+) towards dopaminergic mesencephalic neurones in primary culture.
    Callier S; Le Saux M; Lhiaubet AM; Di Paolo T; Rostène W; Pelaprat D
    J Neurochem; 2002 Jan; 80(2):307-16. PubMed ID: 11902121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment.
    Han BS; Hong HS; Choi WS; Markelonis GJ; Oh TH; Oh YJ
    J Neurosci; 2003 Jun; 23(12):5069-78. PubMed ID: 12832530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture.
    Michel PP; Hefti F
    J Neurosci Res; 1990 Aug; 26(4):428-35. PubMed ID: 1977925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GM1 ganglioside improves dopaminergic markers of rat mesencephalic cultures treated with MPP+.
    Dalia A; Neff NH; Hadjiconstantinou M
    J Neurosci; 1993 Jul; 13(7):3104-11. PubMed ID: 8101212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-Methyl-4-phenylpyridine (MPP+) is toxic to mesencephalic dopamine neurons in culture.
    Mytilineou C; Cohen G; Heikkila RE
    Neurosci Lett; 1985 Jun; 57(1):19-24. PubMed ID: 3875812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural alterations induced by 1-methyl-4-phenylpyridinium (MPP+) in canine substantia nigra and rat mesencephalon in vitro.
    Christie-Pope BC; Burns RS; Whetsell WO
    Exp Neurol; 1989 Jun; 104(3):235-40. PubMed ID: 2785927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.